Trademark: 90266118
Word
TEVA
Status Date
Tuesday, December 19, 2023
Registration Number
7249759
Registration Date
Tuesday, December 19, 2023
Filing Date
Tuesday, October 20, 2020
Published for Opposition
Tuesday, March 16, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
The mark consists of two curved band designs that begins at the bottom center of an outlined rectangle and rise up toward the upper right hand corner of the rectangle. In the center of the curved band design is a large circle with an outline around the left side. In the bottom right hand corner is the word ''TEVA'' in lower case letters. The ''V'' in the word ''TEVA'' is formed by 2 leaf shapes. The entire mark is outlined by a thin line in the shape of a rectangle.
The English translation of the word "TEVA" in the mark is "nature".
Dec 19, 2023
Notice Of Registration Confirmation Emailed
Dec 19, 2023
Registered-Principal Register
Nov 14, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 13, 2023
Allowed Principal Register - Sou Accepted
Nov 13, 2023
Statement Of Use Processing Complete
Nov 8, 2023
Use Amendment Filed
Nov 8, 2023
Teas Statement Of Use Received
May 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2023
Sou Extension 4 Granted
Apr 28, 2023
Sou Extension 4 Filed
Apr 28, 2023
Sou Teas Extension Received
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 3 Granted
Nov 2, 2022
Sou Extension 3 Filed
Nov 2, 2022
Sou Teas Extension Received
May 17, 2022
Sou Extension 3 Denial Letter Prepared
May 17, 2022
Sou Extension 3 Denial Letter Prepared
May 17, 2022
Sou Extension 3 Filed
May 17, 2022
Case Assigned To Intent To Use Paralegal
May 10, 2022
Sou Teas Extension Received
May 11, 2022
Notice Of Approval Of Extension Request E-Mailed
May 9, 2022
Sou Extension 2 Granted
May 9, 2022
Sou Extension 2 Filed
May 9, 2022
Sou Teas Extension Received
Nov 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2021
Sou Extension 1 Granted
Nov 5, 2021
Sou Extension 1 Filed
Nov 5, 2021
Sou Teas Extension Received
May 11, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 16, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 16, 2021
Published For Opposition
Feb 24, 2021
Notification Of Notice Of Publication E-Mailed
Feb 9, 2021
Approved For Pub - Principal Register
Feb 9, 2021
Examiner's Amendment Entered
Feb 9, 2021
Notification Of Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment -Written
Feb 5, 2021
Assigned To Examiner
Dec 9, 2020
Notice Of Design Search Code E-Mailed
Dec 8, 2020
New Application Office Supplied Data Entered
Oct 23, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
